THE VALUE OF PMAPK AND PAKT IN HER2+BREAST CANCER WITH ANTHRACYCLINE-BASED NEOADJUVANT CHEMOTHERAPY

被引：0
|
作者：
Huang, L. [1 ,2 ]
Chen, T. [3 ]
Chen, C. [1 ,2 ]
Chen, S. [1 ,2 ]
Liu, Y. [1 ,2 ]
Wu, J. [1 ,2 ]
Shao, Z. [1 ,2 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China
[2] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China
[3] Shenzhen Sixth Peoples Hosp, Dept Thyroid & Breast Surg, Shenzhen, Peoples R China
来源：
BREAST | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [31] Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer
    Mills, Paul J.
    Ancoli-Israel, Sonia
    Parker, Barbara
    Natarajan, Loki
    Hong, Suzi
    Jain, Shamini
    Sadler, Georgia R.
    von Kaenel, Roland
    BRAIN BEHAVIOR AND IMMUNITY, 2008, 22 (01) : 98 - 104
  • [32] Predictive factors for anthracycline-based chemotherapy for human breast cancer
    Miyoshi, Yasuo
    Kurosumi, Masafumi
    Kurebayashi, Junichi
    Matsuura, Nariaki
    Takahashi, Masato
    Tokunaga, Eriko
    Egawa, Chiyomi
    Masuda, Norikazu
    Kono, Seishi
    Morimoto, Koji
    Kim, Seung Jin
    Okishiro, Masatsugu
    Yanagisawa, Tetsu
    Ueda, Satsuki
    Taguchi, Tetsuya
    Tamaki, Yasuhiro
    Noguchi, Shinzaburo
    BREAST CANCER, 2010, 17 (02) : 103 - 109
  • [33] Predictive factors for anthracycline-based chemotherapy for human breast cancer
    Yasuo Miyoshi
    Masafumi Kurosumi
    Junichi Kurebayashi
    Nariaki Matsuura
    Masato Takahashi
    Eriko Tokunaga
    Chiyomi Egawa
    Norikazu Masuda
    Seishi Kono
    Koji Morimoto
    Seung Jin Kim
    Masatsugu Okishiro
    Tetsu Yanagisawa
    Satsuki Ueda
    Tetsuya Taguchi
    Yasuhiro Tamaki
    Shinzaburo Noguchi
    Breast Cancer, 2010, 17 : 103 - 109
  • [34] Bcl2 Expression Predicts Clinical Outcome of Combined Targeted Therapies of HER2+/ER+ and the Potential Benefit of Anthracycline-based Chemotherapy of HER2+Breast Cancer (BC)
    Abdel-Fatah, T. M.
    Barros, F.
    Green, A.
    Dickinson, P.
    Moseley, P.
    Ian, O. E.
    Chan, S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S382 - S382
  • [35] The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients
    Ding, Yuqin
    Ding, Kaijing
    He, Xiangming
    Mo, Wenju
    Liang, Chenlu
    Gong, Lijie
    Huang, Yuting
    Ding, Xiaowen
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17
  • [36] Bisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer
    Chavez-MacGregor, Mariana
    Brown, Erika
    Lei, Xiudong
    Litton, Jennifer
    Meric-Bernstram, Funda
    Mettendorf, Elizabeth
    Hernandez, Leonel
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Gonzalez-Angulo, Ana Maria
    CANCER, 2012, 118 (02) : 326 - 332
  • [37] Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
    Zhao, Ying-Chun
    Wang, Yan
    Ni, Xiao-Jian
    Li, Yong
    Wang, Xiu-Ming
    Zhu, Yong-Yun
    Luo, Chuan-Yu
    MOLECULAR MEDICINE REPORTS, 2014, 9 (02) : 614 - 620
  • [38] Clinical and Pathological Features of Breast Cancer Associated with the Pathological Complete Response to Anthracycline-Based Neoadjuvant Chemotherapy
    Keskin, Serkan
    Muslumanoglu, Mahmut
    Saip, Pinar
    Karanlik, Hasan
    Guveli, Murat
    Pehlivan, Esmehan
    Aydogan, Fatma
    Eralp, Yesim
    Aydiner, Adnan
    Yavuz, Ekrem
    Ozmen, Vahit
    Igci, Abdullah
    Topuz, Erkan
    ONCOLOGY, 2011, 81 (01) : 30 - 38
  • [39] ANTHRACYCLINE-BASED NEOADJUVANT CHEMOTHERAPY AND HYPERMETHYLATION OF A TUMOUR-SUPPRESSOR GENE IN LOCALLY ADVANCED BREAST CANCER
    Kartini, D.
    Pattiapon, L. A.
    Utomo, A.
    Soetrisno, E.
    Rustamadji, P.
    Cornain, S.
    Sastranegara, F.
    Masykura, N.
    Yulian, E. D.
    Kurnia, A.
    Ramli, M.
    EJC SUPPLEMENTS, 2011, 9 (01): : 15 - 15
  • [40] Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors
    Rouzier, R
    Mathieu, MC
    Sideris, L
    Youmsi, E
    Rajan, R
    Garbay, JR
    André, F
    Marsiglia, H
    Spielmann, M
    Delaloge, S
    CANCER, 2004, 101 (05) : 918 - 925
12345